Drug Profile
PF 2413873
Alternative Names: PF 0243873; PF-02413873; PF-2413873Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Class Pyrazoles
- Mechanism of Action Progesterone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Endometriosis
Most Recent Events
- 27 Jan 2010 Discontinued - Phase-I for Endometriosis in Belgium (PO)
- 27 Jan 2010 Discontinued - Phase-I for Endometriosis in USA (PO)
- 28 Nov 2008 Phase-I clinical trials in Endometriosis in USA (PO)